thiazoles has been researched along with gossypol in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Mohanna, FA; Cooke, E; Hallett, MB | 1 |
Coyle, T; Levante, S; Shetler, M; Winfield, J | 1 |
Boeddrich, A; Heiser, V; Lehrach, H; Lurz, R; Nordhoff, E; Scherzinger, E; Schugardt, N; Wanker, EE | 1 |
Bauer, JA; Bradford, CR; Carey, TE; Fisher, SG; Ji, M; Narayan, A; O'Connell, KM; Oliver, CL; Ubell, ML; Wang, S; Wolter, KG; Wu, X | 1 |
Tang, Y; Wu, XM; Zhang, DY | 1 |
Jia, G; Wu, D; Xu, L; Xu, Y; Zhan, Y | 1 |
An, QX; Chen, R; Huang, XF; Mu, SJ; Wu, DC; Xia, AJ; Zhang, XQ | 1 |
1 review(s) available for thiazoles and gossypol
Article | Year |
---|---|
[Progress in small-molecule inhibitors of Bcl-2 family proteins].
Topics: Antimycin A; Antineoplastic Agents; Apoptosis; bcl-X Protein; Benzopyrans; Biphenyl Compounds; Cell Line, Tumor; Drug Design; Drugs, Chinese Herbal; Gossypol; Humans; Nitriles; Nitrophenols; Piperazines; Proto-Oncogene Proteins c-bcl-2; Structure-Activity Relationship; Sulfonamides; Thiazoles; Thiazolidinediones | 2008 |
6 other study(ies) available for thiazoles and gossypol
Article | Year |
---|---|
Diacylglycerol kinase inhibitor, R59022, potentiates neutrophil oxidase activation by Ca2+-dependent stimuli. Evidence for two separate but convergent pathways.
Topics: Animals; Calcimycin; Calcium; Diacylglycerol Kinase; Enzyme Activation; Gossypol; Luminescent Measurements; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxidoreductases; Phosphotransferases; Protein Kinase C; Pyrimidinones; Rats; Thiazoles | 1987 |
In vitro and in vivo cytotoxicity of gossypol against central nervous system tumor cell lines.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Central Nervous System Neoplasms; Glioma; Gossypol; Humans; Isoenzymes; L-Lactate Dehydrogenase; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Rats; Tetrazolium Salts; Thiazoles; Transplantation, Heterologous; Tumor Cells, Cultured | 1994 |
Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy.
Topics: Animals; Antibodies, Monoclonal; Benzoates; Benzothiazoles; Biphenyl Compounds; Congo Red; COS Cells; Gossypol; Humans; Huntingtin Protein; Huntington Disease; Melatonin; Nerve Tissue Proteins; Nuclear Proteins; Peptides; Rifampin; Thiazoles | 2000 |
In vitro effects of the BH3 mimetic, (-)-gossypol, on head and neck squamous cell carcinoma cells.
Topics: Apoptosis; bcl-X Protein; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dimerization; Dose-Response Relationship, Drug; Drug Resistance; Fibroblasts; Gossypol; Head and Neck Neoplasms; Humans; In Situ Nick-End Labeling; Inhibitory Concentration 50; Peptide Fragments; Protein Structure, Tertiary; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Suppressor Protein p53 | 2004 |
Design and synthesis of a gossypol derivative with improved antitumor activities.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Colony-Forming Units Assay; Drug Screening Assays, Antitumor; Gossypol; Humans; Indicators and Reagents; Models, Molecular; Tetrazolium Salts; Thiazoles | 2009 |
Inhibition of proliferation of prostate cancer cell line, PC-3, in vitro and in vivo using (-)-gossypol.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Cell Survival; Contraceptive Agents, Male; Gossypol; Humans; In Situ Nick-End Labeling; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Microvessels; Microvilli; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Proliferating Cell Nuclear Antigen; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Tetrazolium Salts; Thiazoles; Xenograft Model Antitumor Assays | 2010 |